Innovation Capital

Innovation Capital SAS is a venture capital firm specializing in early stage, emerging growth, and later venture financing. The firm focuses on creation and post creation development and acquiring capital and developing small and medium-sized companies and also provides growth capital. It prefers to invest in telecommunications, information technology, biotechnology, biopharmaceutical, life sciences, industrials, medical, medical devices, clean technologies and advanced materials, energy, chemistry, new materials, healthcare services, and other healthcare and e-healthcare related industries. The firm seeks to invest in companies based in the United States, and Europe with a focus on France and Switzerland. It typically makes an initial investment up to €6 million ($8.37 million) in companies with revenues up to €50 million ($69.77 million). It may invest up to €10 million ($13.95 million) over several rounds of financing. The firm takes active part on the board of directors of its portfolio companies. Innovation Capital SAS was founded in 1996 and is headquartered in Paris, France with an additional office in the United States. As of May 30, 2016, Innovation Capital SAS operates as a subsidiary of LBO France.

Michel Desbard

Venture Partner, Information Technology

Valéry Huot

Managing Partner, Information Technology

Franck Noiret

General Partner, Information Technology

Chantal Parpex

President and Managing Partner, Healthcare

Frédéric Téboul

CFO and General Secretary

58 past transactions

Aldebaran Robotics

Series C in 2011
Aldebaran Robotics designs, manufactures, and sells autonomous humanoid robots for entertainment purposes. The robots are also used for reception, assistance, home care, and autism therapy. Aldebaran Robotics’ products include NAO: a 58-cm tall humanoid robot developed to serve as a friendly companion that moves, recognizes, hears, and talks to human beings; Pepper: a social robot that converses with humans, recognizes them, and reacts to their emotions while moving and living autonomously; and Romeo: a 140-cm humanoid robot intended to deepen research on assistance for the elderly and those who have lost autonomy that has the ability to open doors, climb stairs, and grab objects on a table. Aldebaran Robotics was founded in 2005 and is based in Paris, France.

Iwedia Technologies

Series C in 2006
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.

Paragon ID

Post in 2016
Paragon ID is a leader in identification solutions in the e-ID, transport, smart cities, traceability & brand protection sectors. Using the latest technologies such as RFID and NFC, Paragon ID provides smart cards, tickets, labels and tags to worldwide clients in diverse markets including public transport, manufacturing, logistics, gaming and retail. Paragon ID employs more than 600 staff, with manufacturing sites in three continents (US, Europe and Asia), close to its customers. Paragon ID is a part of Paragon Group, which is a leading provider of identification and customer communications services, and has a total turnover in excess of €650 million, and close to 5,000 employees. The Group combines generations of experience, with the latest innovations in technology and smart data, to enable responsive and meaningful interactions, between organisations and their customers.

Citilog S.A.

Series D in 2006
Citilog is a leading provider of advanced video-based monitoring and surveillance products that enable traffic, security and safety management operators to identify incidents in real time instead of traditional passive solutions that act only to verify an incident after it has already come and gone. Citilog offers solutions to address Road and Infrastructure Safety, Security, Mobility and Sustainable Growth.

H4D

Series B in 2016
Founded in 2008, H4D has remained true to its original mission: to overcome isolation from health care, whether geographic or social, while supporting preventative medicine initiatives, as well as the treatment and the monitoring of chronic diseases. They are committed to ensuring that health checks become a straightforward and accessible recourse to everyone. Their pledge to provide health care solutions for everyone, regardless of their geographic location or social environments, coheres with Their respect or medical and paramedical professionals. H4D’s health programs are always integrated into a global health plan and are supported by systematic communication with local healthcare stakeholders.

BIOMODEX

Seed Round in 2016
BIOMODEX is an innovative medical technology company based in Paris and Boston using 3D printing to create tissue-like anatomical twins from medical images, for patient-specific rehearsal and advanced training. The anatomically accurate twin is designed to provide critical tactile feedback to users which, when paired with our simulated blood flow stations, offers a unique and tailored end to end physician experience.

Ipracom

Series B in 2005
Ipracom SA develops software solutions focusing on PDA's and smart-phones. The company offers products such as Ipra*Cool and Ipra*PC that enable users to connect to PC's for accessing files or check e-mail. It also develops software for vertical applications. The company's clientele includes Orange, Bouygues Telecom, and Smart Communications. Ipracom is based in Massy, France. As of November 12, 2007, Ipracom SA is a subsidiary of Maeglin Software.

Iwedia Technologies

Series D in 2007
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.

Novaled

Series C in 2009
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.

Aldebaran Robotics

Series A in 2007
Aldebaran Robotics designs, manufactures, and sells autonomous humanoid robots for entertainment purposes. The robots are also used for reception, assistance, home care, and autism therapy. Aldebaran Robotics’ products include NAO: a 58-cm tall humanoid robot developed to serve as a friendly companion that moves, recognizes, hears, and talks to human beings; Pepper: a social robot that converses with humans, recognizes them, and reacts to their emotions while moving and living autonomously; and Romeo: a 140-cm humanoid robot intended to deepen research on assistance for the elderly and those who have lost autonomy that has the ability to open doors, climb stairs, and grab objects on a table. Aldebaran Robotics was founded in 2005 and is based in Paris, France.

Stantum

Series B in 2009
Stantum, Inc. designs and manufactures multitouch surface controllers. Its products include Lemur, which is a control surface for audio and media applications; and DEXTER, a laptop sized control surface, which is used for controlling digital audio workstations. The company’s products are used by musicians, composers, discjockies, media artists, researchers, and developers. It offers its products through distributors and retailers internationally. The company was formerly known as JazzMutant SAS and changed its name in 2007. Stantum, Inc. was founded in 2002 and is based in Bordeaux, France with a liaison office in Tokyo, Japan.

Santaris Pharma

Series C in 2007
Santaris Pharma A/S is a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies. The LNA Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. The company’s research and development activities focus on infectious diseases and cardiometabolic disorders, while partnerships with major pharmaceutical companies include a range of therapeutic areas including cancer, cardiovascular disease, infectious and inflammatory diseases, and rare genetic disorders. The company has strategic partnerships with miRagen Therapeutics, Shire PLC, Pfizer, GlaxoSmithKline, and Enzon Pharmaceuticals. As part of its broad patent estate, the company holds exclusive worldwide rights to manufacture, have manufactured and sell products that contain LNA as an active ingredient for studies performed with a view to obtaining marketing approval. Santaris Pharma A/S, founded in 2003, is headquartered in Denmark with operations in the United States.

Radio Systemes Ingenierie

Series C in 2004
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.

IntegraGen SA

Venture Round in 2010
IntegraGen is a French biotech company based on the Genopole life science park in Evry, near Paris. It leverages its unique intellectual property, research expertise and privileged access to sample libraries to develop molecular markers for central nervous system and metabolic diseases. IntegraGen notably uses its proprietary technology platforms to provide genomics services to the pharmaceutical industry, biotech firms and other research providers.
At Santen, they’re innovating therapies to improve the quality of life for patients worldwide. Their single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a globally competitive company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Their clinical development network now spans three continents, with centers in Europe, Japan, and the United States.

BioSerenity, SAS

Series A in 2017
BioSerenity souhaite aider la communauté scientifique à mieux comprendre l'épilepsie pour mieux la soigner. Une fois anonymisées et privées de tout lien avec le patient, les données recueillies seront mise à disposition des chercheurs de l'Institut du Cerveau et de la Moelle épinière (ICM). C'est un pas décisif pour faire avancer la recherche sur l'épilepsie et améliorer le futur du diagnostic

GeoSpock Ltd.

Series B in 2019
GeoSpock Limited develops data indexing platform, which provides analytics, builds insight, and enables predictions across space and time. The company's products include GeoSpock DB Discovery and GeoSpock DB Enterprise that offers cloud-based database service for all location tagged information and enables the user to carry out dynamic data fusion and query complex data for performance analytics. It powers any location based service from real time tracking of entire logistics fleets to local taxi finding application. The company was incorporated in 2013 and is based in Cambridge, United Kingdom with additional offices in Tokyo, Japan; and Singapore.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.

Drug Abuse Sciences

Series A in 2001
Drug Abuse Sciences develops and commercializes therapies for the treatment of alcohol and drug addictions. It offers Naltrexone Depot, a sustained-release formulation of Naltrexone for the treatment of alcohol and opiate addictions; DAS-431 for the treatment of cocaine addiction; and Buprenorphine Depot, a sustained-release formulation of buprenorphine for the treatment of heroin and various opiate addictions. Drug Abuse Sciences is based in Menlo Park, California.

Teem Photonics S.A.

Venture Round in 2003
Teem Photonics develops passively Q-switched microlasers as well as Photonics Integrated Circuits based on ion exchange technology. The combination of passive Q-switching and microlaser technologies results in sources distinctive for sub nanosecond, high peak power pulses, generated from compact packages at high repetition rates.

Kayentis

Venture Round in 2016
Kayentis, SAS provides data and real-time information capture and collection solutions. It offers Digital Pen Paper (DPP) solutions for the clinical trial industry. The company also provides Clin'Form that allows data written using a DPP to be recorded in an information system and shared via a Web portal. It serves life sciences, finance, and manufacturing markets. The company was incorporated in 2004 and is headquartered in Gif sur Yvette, France.

EKINOPS S.A.

Post in 2017
Ekinops is a provider of next-generation optical transport solutions for service providers and private networks. Its carrier-grade solutions leverage expertise in 10G transmission, aggregation and Forward Error Correction (FEC) to allow operators to cost-effectively increase data transport capacity over dark fiber, CWDM, DWDM, SONET/SDH, IP and SAN networks.

Radio Systemes Ingenierie

Series D in 2009
Radio Systemes Ingenierie S.A. provides wireless communication systems. It offers Visioguard, a wireless alarm system that provide remote video monitoring, local monitoring with a TV or a monitor, integrated Internet-server, and emails with attached video-files. The company was founded in 2000 and is based in Strasbourg, France.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.

Expway SA

Venture Round in 2016
EXPWAY is the world leader in Mobile Broadcast and Multicast Solutions. The company's fastest growing market is on LTE BROADCAST i.e. eMBMS. Expway provides eMBMS BM-SC SERVERs that allow the operator to create multicast streams, both live TV and push files in any format, and broadcast them at the LTE network. Its eMBMS MIDDLEWARE controls the LTE modem, and receives and decodes the broadcast streams on the device.
At Santen, they’re innovating therapies to improve the quality of life for patients worldwide. Their single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a globally competitive company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Their clinical development network now spans three continents, with centers in Europe, Japan, and the United States.

Voluntis, Inc.

Series D in 2014
Voluntis, Inc. develops digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. It offers Insulia, a prescription-only medical device that provides type 2 diabetes patients with insulin dose recommendations and educational coaching messages based on blood glucose values and other diabetes-related data; and Diabeo, a digital solution for type 1 and type 2 patients treated on a basal-bolus insulin regimen, which suggests insulin dosage, through algorithmic calculations that are specific to the patient and based on their particular doses. Voluntis, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.

Zealand Pharma

Venture Round in 2005
Zealand Pharma A/S, a biotechnology company, engages in the discovery and development of peptide-based medicines in Denmark. It has a portfolio of medicines in development stage focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes glepaglutide, a long acting GLP-2 analog, which is in Phase 3 clinical trials for the treatment of short bowel syndrome; and dasiglucagon, a stable glucagon analog for the treatment of severe hypoglycemia in diabetes and congenital hyperinsulinism, as well as for use in dual-hormone artificial pancreas for automated diabetes management. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; and Beta Bionics, Inc. to initiate home-use trial of the iLet bionic pancreas with dasiglucagon for autonomous bihormonal treatment of type 1 diabetes, as well as research agreement with Orbit Discovery Ltd. and Torrey Pines Institute for Molecular Studies. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.

Cytheris

Series D in 2010
Cytheris is a privately held clinical-stage biopharmaceutical company focused on research and development of therapies for immune modulation. These drugs aim at reconstituting and enhancing the immune system of patients suffering from cancer, chronic viral or bacterial infections such as HIV, HCV, and HBV or lympho-depleting treatments such as chemotherapy, radiotherapy, bone marrow transplantation (BMT) and hematopoietic cell transplantation (HCT).

FittingBox

Series B in 2014
FittingBox SAS operates a platform for virtual fitting solutions in order to ensure glasses and sunglasses fitting. It offers web based solution, virtual mirror for optical website, virtual mirror for e commerce website, and frames data base; in store solution, interactive storefront window, interactive kiosk, and virtual mirror on ipad. The company was founded in 2006 and is based in Labège, France with additional office in Florida, United States.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.

6WIND

Seed Round in 2000
6WIND enables the industry’s highest performance in physical and virtual environments. Through its innovative software architecture, 6WINDGate can deliver over 10x performance improvements in data plane processing throughput, compared to standard Linux networking stacks. 6WINDGate provides an extensive set of Layer 2 through Layer 4 networking protocols, enabling best-in-class cost-performance at the system level and minimizing CAPEX for high-end networking equipment. With advanced technology that maximizes the performance of networking features running within a virtualized environment, 6WINDGate delivers industry-leading networking performance on commodity hardware platforms. This optimizes networking resources in virtual environments, enabling significant OPEX reductions compared to solutions based on standard OS networking stacks.

Novaled

Series B in 2005
Novaled AG is a world-class technology provider in organic light-emitting diode (OLED) technologies. With expertise in synthetic and analytical chemistry, it offers complete solutions for the organic electronic markets, commercializing Novaled's Doping technology and materials. Novaled has developed long-term partnerships with major OLED players worldwide. Its strong IP position in OLED technology is based on more than 500 patents granted or pending. In operation since March 2003, Novaled is headquartered in Dresden, Germany with branch offices in Asia.

Theradiag SA

Series A in 2000
Theradiag is a France-based company which develops and markets biological diagnostic tools. The company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.

Kaidara Software

Series B in 2003
Provider of advanced service and support solutions for manufacturers of complex products. The company offers customer service software which provides first-time responses to customers' requests via self-service features on a Web site and through assisted interaction channels.

NEMOPTIC

Series D in 2006
Nemoptic, an epaper display company, designs and manufactures superior-quality bistable liquid crystal displays (LCD) modules highly suitable for consumer and professional mobile devices.

Wandercraft

Series B in 2017
Wandercraft SAS develops and creates Atalante exoskeleton for patients whose mobility is limited as a result of spinal cord injury, neuromuscular disease, and stroke. Its Atalante is a self-balancing and hands-free exoskeleton for use in health centers for walking rehabilitation. The company was founded in 2012 and is based in Paris, France.

GRAITEC Innovation SAS

Series C in 2005
GRAITEC Advance is a Building Information Modeling (BIM) system that automates the entire structural design and construction documentation process from engineering design and structural analysis to member optimization, detailing and fabrication. GRAITEC Advance provides designers and detailers with an optimal working environment with tools to create and completely carry out their construction projects: optimization of construction materials, elimination of project inconsistencies, faster study turnaround time, automatic document creation, project history and tracking, fluid communication with project partners etc. Founded in 1986, GRAITEC is an Autodesk Platinum Partner in Europe and America and a long standing international Autodesk Partner and independent developer of high performance BIM Solutions for the AEC industry. Operating throughout 29 offices across 12 countries worldwide, GRAITEC offers its clients an extensive range of established software solutions combined with the full portfolio of Autodesk products and BIM suites which help address the most demanding projects needs and maximize productivity, efficiency and performance. GRAITEC is an innovation focused company whose products are used by more than 40,000 construction professionals worldwide.

Iwedia Technologies

Series B in 2005
Iwedia Technologies S.A., through its divisions, provides software solutions for connected audiovisual digital terminals; and engineering services in the whole digital image chain. It also offers software components and customized solutions. The company was founded in 2004 and is headquartered in Rennes, France.

Maeglin Software

Venture Round in 2012
Maeglin Software is dedicated to freeing-up your mobile life by delivering state-of-the-art mobile Value Added Services to the Telecom industry.
At Santen, they’re innovating therapies to improve the quality of life for patients worldwide. Their single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a globally competitive company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Their clinical development network now spans three continents, with centers in Europe, Japan, and the United States.

OpenHealth

Private Equity Round in 2017
OpenHealth is a provider of real-time processing of health consumption data.

TxCell S.A.

Series B in 2008
TxCell, a spin off of Inserm (France's National Institute for Health and Medical Research) located in the technology park of Sophia Antipolis, near Nice in southern France, is developing cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases with high medical need using its unique and proprietary technology platform based on the properties of Type 1 regulatory T lymphocytes (Tr1 cells). The company has completed enrollment of a PhI/II study in refractory Crohn's disease patients and has reported first positive results. The company plans to initiate a PhIIb study in the same patient population and bring a second product candidate into a PhI/II study in refractory rheumatoid arthritis patients.

cacaoTV

Seed Round in 2008
Introduction to cacaoTV cacaoTV is a software that allows to view a streaming audio video media (i.e. TV channels) based on Peer to Peer (P2P) technology. cacaoTV works by using P2P technology, thus everyone when viewing media with cacaoweb client, the viewers upload content at the same time the programs are downloaded and viewed. cacaoweb creates a local stream on localhost and that stream is then read by Windows Media Player, Real Player or other media players. Since all viewers will upload content when viewing media, everyone becomes a broadcaster (server) without the cost of traditional streaming. And hence, the more users are online, the faster the programs can be loaded. And it will automatically find different connection nodes and download stream data from the nearest location (nodes). The good thing is, stream data is buffering in the memory, not on the hard disk. Channel Availability and Reliability Currently, most of the media contents are TV channels from the USA, and it includes some subscribers-based international channel such as HBO, ESPN, National Geographic and etc. Lately there are some independent channels that broadcast selective collection of media, such as latest blockbuster movies, collection of movies from a celebrity, or whole series of a drama. This kind of channels is created by individual viewers. There are also some radio channels available. Ease of Use and Speed of cacaoTV Just download cacaoweb and install it, and you’re ready to jump on the bandwagon of P2P TV. cacaoweb is able to work perfectly and stream smoothly without any configuration.

Anevia Société Anonyme

Series B in 2009
Anevia provides IPTV and over-the-top (OTT) video solutions for the delivery of live TV and video on demand (VOD) services to TV, PC, and mobile devices. With over 1,000 deployments in 70 countries, representing millions of users and over 25,000 live channels, Anevia is a leader in delivering multiscreen video services infrastructure to telecom operators, broadcast service providers and the hospitality market.

Zesty Limited

Series A in 2015
Zesty Limited, a digital health company, provides on-demand access to healthcare appointments via desktop, tablet, mobile, and cross platform applications in Western Europe. It offers digital tools to healthcare providers for booking and managing appointments, reading letters digitally, and sharing copies of electronic medical records; and digital platform for patients to manage their health care right from their smartphone. It serves customers, including hospitals, community providers, and general practice surgeons. Zesty Limited was formerly known as Zesty Health Limited and changed its name to Zesty Limited in January 2014. The company was incorporated in 2012 and is based in London, United Kingdom.

Theradiag SA

Series B in 2003
Theradiag is a France-based company which develops and markets biological diagnostic tools. The company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.
At Santen, they’re innovating therapies to improve the quality of life for patients worldwide. Their single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a globally competitive company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Their clinical development network now spans three continents, with centers in Europe, Japan, and the United States.

Wirecom Technologies

Series A in 2006
WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences

Wandercraft

Series A in 2015
Wandercraft SAS develops and creates Atalante exoskeleton for patients whose mobility is limited as a result of spinal cord injury, neuromuscular disease, and stroke. Its Atalante is a self-balancing and hands-free exoskeleton for use in health centers for walking rehabilitation. The company was founded in 2012 and is based in Paris, France.

EI-Technologies

Venture Round in 2008
EI-Technologies – SA provides IT consulting and internet software development services. The company also offers Salesforce solutions, workplace solutions known as EI-Workplace, and training on Salesforce technologies at EI-Institut. EI-Technologies – SA was incorporated in 1994 and is based in Paris, France. As of May 29, 2020, EI-Technologies – SA operates as a subsidiary of Cognizant Technology Solutions Corporation.

FittingBox

Venture Round in 2009
FittingBox SAS operates a platform for virtual fitting solutions in order to ensure glasses and sunglasses fitting. It offers web based solution, virtual mirror for optical website, virtual mirror for e commerce website, and frames data base; in store solution, interactive storefront window, interactive kiosk, and virtual mirror on ipad. The company was founded in 2006 and is based in Labège, France with additional office in Florida, United States.

Wirecom Technologies

Series B in 2007
WIRECOM Technologies is a French company with state-of-the-art technology and an experience of over 10 years. Committed to sustainable development and the fight against global warming, WIRECOM Technologies designs and develops solutions to optimise energy efficiency in buildings and residences
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company’s orthobiologics pipeline products comprise MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products include KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaborations with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is based in Schlieren, Switzerland.

RocTool

Venture Round in 2004
RocTool S.A. provides induction heating systems, tooling hardware products, power units, and peripherals in France and internationally. It offers generators, interfaces, and cooling units; and installation, design, and engineering services. The company serves automotive, consumer electronics, consumer goods, aerospace, and medical markets. RocTool S.A. is headquartered in Le Bourget du Lac, France.

Kuros Biosciences AG

Series A in 2002
Kuros Biosciences AG, a biopharmaceutical company, engages in the discovery, development, and commercialization of biopharmaceutical products for the treatment and prevention of chronic diseases in the United States, the United Kingdom, and internationally. Its sealants pipeline products include Neuroseal EU and US for the treatment of dural sealant cranial. The company’s orthobiologics pipeline products comprise MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products include KUR-111, which has completed Phase II clinical trial for the treatment of tibial plateau fractures; KUR-113, which completed Phase II clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase I trial for the treatment of spinal interbody fusion. The company has collaborations with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. Kuros Biosciences AG is based in Schlieren, Switzerland.
At Santen, they’re innovating therapies to improve the quality of life for patients worldwide. Their single focus in ophthalmology enables us to challenge unmet needs in the field—through passionate research, successful collaboration, and clarity of commitment. With over 120 years of investigative insight, Santen remains committed to the discovery, exploration, and development of ophthalmic therapies. Now, and into the future. As a globally competitive company, Santen is often expanding to accommodate new and evolving initiatives in ophthalmic research, regulatory management, production, marketing, or distribution. Their clinical development network now spans three continents, with centers in Europe, Japan, and the United States.

OMNIlife science

Venture Round in 2010
OMNIlife science, Inc. was founded in 1999 as an organization committed to the design, manufacture and distribution of high quality orthopaedic devices. Their corporate headquarters are located in Massachusetts.